The absolute bioavailability of oral melatonin

Journal of Clinical Pharmacology

Volumn 40, Issue 7, 2000, Pages 781-784

  Demuro, R L ^a   Nafziger, A N ^a,b   Blask, D E ^a   Menhinick, A M ^b   Bertino, J S ^a,b  

^a BASSETT HEALTHCARE   (United States)

^b BASSETT RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INDOLEAMINE; MELATONIN;

ARTICLE; CLINICAL TRIAL; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG METABOLISM; FEMALE; FIRST PASS EFFECT; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; PHASE 1 CLINICAL TRIAL; PREMENOPAUSE; TABLET FORMULATION;

EID: 0033638766     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1177/00912700022009422     Document Type: Article

References (14)

1. Melatonin in humans
2. Melatonin: Therapeutic use in sleep disorders
3. The amplitude of endogenous melatonin production is not affected by melatonin treatment in humans
4. Variability bioavailability of oral melatonin
5. Pharmacokinetics of melatonin in human sexual maturation
6. Bioavailability of oral melatonin in humans
7. Guidelines for prescribing melatonin
8. Stability of melatonin in aqueous solution
9. New sensitive serum melatonin radioimmunoassay employing the Kennaway G280 antibody: Syrian hamster morning adrenergic response
10. TopFit: A PC based pharmacokinetic/pharmacodynamic data analysis program
11. Melatonin administration to dogs
12. The half-life of melatonin elimination from rat plasma
13. Serum melatonin after a single aqueous subcutaneous injection in Syrian hamsters
14. Pharmacokinetics of melatonin in man: First pass metabolism